Tranexamic acid and Ifosfamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tranexamic acid (tranexamic acid) and Ifosfamide (ifosfamide). Common drug interactions include aplastic anaemia among females and bacteraemia among males.

The phase IV clinical study analyzes what interactions people have when they take Tranexamic acid and Ifosfamide. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Tranexamic acid?

Tranexamic acid has active ingredients of tranexamic acid. It is often used in heavy or prolong menstrual bleeding. eHealthMe is studying from 8,687 Tranexamic acid users. Check the latest studies of Tranexamic acid.

What is Ifosfamide?

Ifosfamide has active ingredients of ifosfamide. eHealthMe is studying from 21,285 Ifosfamide users. Check the latest studies of Ifosfamide.



On Jul, 11, 2026

20 people who take Tranexamic acid and Ifosfamide together, and have interactions are studied.

Tranexamic acid and Ifosfamide drug interactions.

What are the common drug interactions of Tranexamic Acid and Ifosfamide, by gender? *:

female:

  1. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  2. Drug ineffective

male:

  1. Bacteraemia (presence of bacteria in the blood)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Spinal cord compression
  4. Urinary tract infection
  5. Urinary tract obstruction
  6. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  7. Mucosal inflammation (infection of mucous membrane)
  8. Pleural effusion (water on the lungs)
  9. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  10. Brain injury

What are the common drug interactions of Tranexamic Acid and Ifosfamide, by age (0-1 to 60+)? *:

0-1:

  1. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)

2-9:

n/a

10-19:

  1. Fatigue (feeling of tiredness)
  2. Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries))
  3. Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
  4. Mucosal inflammation (infection of mucous membrane)
  5. Drug ineffective

20-29:

  1. Bacteraemia (presence of bacteria in the blood)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Pleural effusion (water on the lungs)
  4. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  5. Brain injury

30-39:

  1. Abdominal pain
  2. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  3. Platelet count decreased
  4. Respiratory failure (inadequate gas exchange by the respiratory system)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Septic shock (shock due to blood infection)
  7. Spinal cord compression
  8. Urinary tract infection
  9. Urinary tract obstruction
  10. Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Sarcoma (rare cancers that develop in the muscle, bone, nerves, cartilage, tendons, blood vessels and the fatty and fibrous tissues): 5 people, 25.00%
  2. Osteosarcoma (a cancerous (malignant) bone tumour): 5 people, 25.00%
  3. Lymphoma (cancer that begins in immune system cells): 5 people, 25.00%
  4. Nosebleed (bleeding from nose): 3 people, 15.00%
  5. Insomnia (sleeplessness): 3 people, 15.00%
  6. Fever: 3 people, 15.00%
  7. Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 15.00%
  8. Abdominal Pain: 3 people, 15.00%
  9. Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 10.00%
  10. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tranexamic acid and Ifosfamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Tranexamic acid and Ifosfamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tranexamic acid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ifosfamide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Tranexamic acid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ifosfamide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tranexamic acid and ifosfamide (the active ingredients of Tranexamic acid and Ifosfamide, respectively), and Tranexamic acid and Ifosfamide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: